Nasdaq26 天
Lobbying Update: $320,000 of BRIDGEBIO PHARMA INC. lobbying was just disclosed
$320,000 of BRIDGEBIO PHARMA INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Creating Hope Reauthorization Act ...
Nasdaq1 个月
BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference
PALO ALTO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical ...